X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (95) 95
female (74) 74
male (71) 71
adult (69) 69
middle aged (65) 65
hematology (61) 61
aged (48) 48
index medicus (39) 39
oncology (38) 38
adolescent (30) 30
prognosis (25) 25
non-hodgkins-lymphoma (23) 23
aged, 80 and over (22) 22
retrospective studies (22) 22
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
treatment outcome (21) 21
chemotherapy (19) 19
disease-free survival (17) 17
transplantation (17) 17
follow-up studies (16) 16
rituximab (14) 14
survival analysis (14) 14
survival rate (13) 13
therapy (13) 13
young adult (13) 13
combined modality therapy (12) 12
bone-marrow-transplantation (11) 11
lymphomas (10) 10
medicine & public health (10) 10
recurrence (10) 10
risk (10) 10
stem-cell transplantation (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
platelet count (9) 9
hematopoietic stem cell transplantation (8) 8
lymphoma, b-cell, marginal zone - pathology (8) 8
risk factors (8) 8
survival (8) 8
thrombosis (8) 8
time factors (8) 8
transplantation, autologous (8) 8
bone marrow (7) 7
cyclophosphamide - administration & dosage (7) 7
disease (7) 7
etoposide - administration & dosage (7) 7
lymphoma (7) 7
minimal residual disease (7) 7
multivariate analysis (7) 7
stem cell transplantation (7) 7
analysis (6) 6
antineoplastic agents - therapeutic use (6) 6
b-cell (6) 6
cancer (6) 6
child (6) 6
cytarabine - administration & dosage (6) 6
disease progression (6) 6
lymphoma, large b-cell, diffuse - mortality (6) 6
lymphoma, large b-cell, diffuse - therapy (6) 6
lymphoma, mantle-cell - therapy (6) 6
mantle cell lymphoma (6) 6
neoplasm staging (6) 6
proportional hazards models (6) 6
prospective studies (6) 6
stem cells (6) 6
thrombosis - etiology (6) 6
antineoplastic agents (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
aspirin (5) 5
bendamustine (5) 5
bone-marrow transplantation (5) 5
diagnosis (5) 5
drug therapy (5) 5
essential thrombocythemia (5) 5
follicular lymphoma (5) 5
gene-expression (5) 5
hematology, oncology and palliative medicine (5) 5
high-dose therapy (5) 5
immunochemotherapy (5) 5
lupus coagulation inhibitor (5) 5
malignancies (5) 5
medical research (5) 5
myelodysplastic syndrome (5) 5
myeloproliferative disorders (5) 5
myeloproliferative disorders - blood (5) 5
platelet aggregation (5) 5
prednisone - therapeutic use (5) 5
pregnancy (5) 5
risk-factors (5) 5
thrombocythemia, essential - blood (5) 5
thrombocythemia, essential - complications (5) 5
transplantation, homologous (5) 5
treatment (5) 5
adults (4) 4
age factors (4) 4
antibodies, monoclonal, murine-derived (4) 4
antibodies, monoclonal, murine-derived - administration & dosage (4) 4
anticardiolipin antibodies (4) 4
bendamustine plus rituximab (4) 4
blood coagulation factors - immunology (4) 4
care and treatment (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia & Lymphoma, ISSN 1042-8194, 05/2012, Volume 53, Issue 5, pp. 1012 - 1012
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2011, Volume 29, Issue 7, pp. 814 - 824
Purpose High-dose chemotherapy with peripheral blood progenitor cell (PBPC) autograft is effective in high-risk lymphoma, particularly with the addition of... 
PROGENITOR CELLS | THERAPY | ONCOLOGY | COMPETING RISK | BONE-MARROW-TRANSPLANTATION | ACUTE MYELOGENOUS LEUKEMIA | AUTOLOGOUS TRANSPLANTATION | NON-HODGKINS-LYMPHOMA | FOLLICULAR LYMPHOMA | STEM-CELL TRANSPLANTATION | MYELODYSPLASTIC SYNDROME | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Hodgkin Disease - pathology | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Neoplasms, Second Primary - mortality | Lymphoma - mortality | Dose-Response Relationship, Drug | Young Adult | Lymphoma - therapy | Time Factors | Statistics, Nonparametric | Hodgkin Disease - mortality | Adult | Female | Lymphoma - pathology | Retrospective Studies | Lymphoma, B-Cell - mortality | Risk Assessment | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Rituximab | Treatment Outcome | Combined Modality Therapy | Transplantation, Autologous - methods | Neoplasms, Second Primary - epidemiology | Disease-Free Survival | Stem Cell Transplantation - methods | Lymphoma, T-Cell - therapy | Hodgkin Disease - therapy | Adolescent | Lymphoma, B-Cell - pathology | Lymphoma, T-Cell - pathology | Survival Analysis | Transplantation, Autologous - adverse effects | Aged | Lymphoma, T-Cell - mortality | Cohort Studies | Stem Cell Transplantation - adverse effects
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2010, Volume 79, Issue 3, pp. 330 - 343
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 3, pp. 375 - 381
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2008, Volume 26, Issue 19, pp. 3166 - 3175
Journal Article